American Health and Drug Benefits
metrics 2024
Navigating the complexities of health care and pharmaceuticals.
Introduction
American Health and Drug Benefits, published by ENGAGE HEALTHCARE COMMUNICATIONS INC, is a pivotal journal dedicated to advancing the understanding of health policy and management in the pharmaceutical sector. Launched in 2009, this journal serves as a vital resource for researchers, practitioners, and policymakers engaged in the dynamic interplay between health care quality, drug accessibility, and effective management strategies. With its ISSN 1942-2962 and E-ISSN 1942-2970, the journal has established itself within the community, evidenced by its 2023 Scopus rankings, including Q4 in Health Policy and Q3 in Strategy and Management. Although currently lacking an open-access model, American Health and Drug Benefits remains a crucial platform for disseminating high-quality research that informs health care delivery and policy decisions in the United States. Its commitment to rigorous scholarship contributes to better health outcomes and fosters innovation in drug benefits management.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
Canadian Journal of Kidney Health and Disease
Fostering collaboration for a healthier future in nephrology.Canadian Journal of Kidney Health and Disease, published by SAGE Publications Inc, is a leading open-access journal dedicated to advancing the field of nephrology. Established in 2014, the journal aims to bridge the gap between research and clinical practice by disseminating high-quality clinical and experimental research findings, reviews, and case studies that focus on kidney health and associated disorders. With an impressive impact factor and ranked in the Q2 category for nephrology, the journal fosters an environment for interdisciplinary collaboration and innovation, enhancing the visibility of crucial advancements in kidney disease research. As an open-access journal, it ensures that valuable knowledge is accessible to researchers, healthcare professionals, and students globally, facilitating a deeper understanding of kidney health issues and promoting improved patient care. Located in the United Kingdom, the journal continues to expand its reach and influence within the nephrology community, leveraging its open-access model to encourage a diverse audience in exploring cutting-edge findings and sharing insights pertinent to kidney health.
Practical Diabetes
Enhancing patient outcomes through cutting-edge diabetes research.Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.
Current Oncology
Connecting the Global Oncology CommunityCurrent Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.
Journal of the American Board of Family Medicine
Connecting Scholars and Practitioners in Family Medicine.The Journal of the American Board of Family Medicine, with ISSN 1557-2625 and E-ISSN 1558-7118, is a prestigious publication dedicated to advancing the field of family medicine. Published by the American Board of Family Medicine, this journal has established itself as a vital resource for researchers, practitioners, and students interested in both family practice and public health. As of 2023, it boasts impressive rankings, being in the Q1 category of Family Practice and the Q2 category of Public Health, Environmental and Occupational Health according to Scopus metrics, reflecting its significant impact and influence in the academic community. The journal's focus on high-quality research ensures that it remains at the forefront of evidence-based practice, fostering the dissemination of knowledge that is critical for improving patient care and outcomes. This journal, although not open-access, provides a wealth of insights and findings relevant to professionals striving to enhance their understanding and implementation of best practices in family medicine. With a converged publication history starting in 2002, it continues to serve as an essential platform for innovative studies and discussions that shape the future of family medicine.
Australian Health Review
Pioneering Research for a Healthier AustraliaAustralian Health Review is a prestigious peer-reviewed journal published by CSIRO PUBLISHING, focusing on the dynamic field of health policy. Established in 1980, this journal has continuously evolved to address contemporary health challenges in Australia and beyond, showcasing research that informs policy decisions and enhances health care delivery. With an impressive Q2 ranking in the sector of Health Policy and a Scopus rank of #162 out of 310, it holds a significant position in the academic community, offering vital insights to researchers, practitioners, and educators alike. Although not an open-access journal, it provides valuable research contributions that advance the discourse in health policy and practice. Located at UNIPARK, BUILDING 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC 3168, AUSTRALIA, the journal's comprehensive scope spans from 1980 to 2024, reflecting on the evolving landscape of health research. By disseminating high-quality studies, the Australian Health Review continues to play an essential role in shaping health policy and improving health outcomes.
Journal of Pharmaceutical Policy and Practice
Elevating the discourse on pharmaceutical practices and policies.Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.
HOSPITAL PHARMACY
Advancing pharmacy practice for better patient care.Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.
AMERICAN JOURNAL OF MANAGED CARE
Elevating health policy discourse for a better tomorrow.AMERICAN JOURNAL OF MANAGED CARE is a premier peer-reviewed journal dedicated to the dissemination of research and insights in the fields of health policy and managed care. Published by Managed Care & Healthcare Communications LLC, this esteemed journal has been instrumental in shaping discussions on healthcare management and policy since its inception in 1996. With a 2023 classification in the first quartile (Q1) for both Health Policy and Medicine (miscellaneous), it stands as a significant resource for researchers, professionals, and students seeking to stay at the forefront of healthcare advancements. While this journal does not offer open access, it provides essential content that influences policy formulation and clinical practices across the United States and beyond. With a robust impact factor and a strategic focus on evidence-based methodologies, the AMERICAN JOURNAL OF MANAGED CARE remains committed to fostering a deeper understanding of managed care systems and improving healthcare delivery.
Primary Care Diabetes
Enhancing understanding of diabetes through collaborative scholarship.Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.
Health Services Research and Managerial Epidemiology
Shaping the future of health policy through scholarly discourse.Health Services Research and Managerial Epidemiology is an esteemed peer-reviewed journal published by SAGE Publications Inc, dedicated to advancing the fields of health services research and epidemiology. With the ISSN 2333-3928, this Open Access journal, available since 2014, aims to foster a deeper understanding of the managerial aspects of epidemiology and its implications for health service delivery. By offering insights into critical healthcare policies and practices, the journal serves as an important resource for researchers, practitioners, and students alike. As of 2023, it is classified in the Q3 quartile for both Epidemiology and Health Policy, ranking within the 31st and 30th percentiles, respectively, in Scopus rankings. The journal’s scope encompasses a wide variety of topics, ranging from health management practices to innovative research methodologies, making it a key platform for disseminating influential work that shapes health policy and public health strategies. Operating out of the United States, at 2455 Teller Rd, Thousand Oaks, CA 91320, it continues to push the boundaries of knowledge in an increasingly vital area of study.